iGlarLixi effectively reduces residual hyperglycaemia in patients with type 2 diabetes on basal insulin: A post hoc analysis from the LixiLan‐L study
Morea, Nicola, Retnakaran, Ravi, Vidal, Josep, Aroda, Vanita R., Liu, Minzhi, Saremi, Aramesh, Giorgino, Francesco
Published in Diabetes, obesity & metabolism (01.09.2020)
Published in Diabetes, obesity & metabolism (01.09.2020)
Get full text
Journal Article
Open questions on basal insulin therapy in T2D: a Delphi consensus
Buzzetti, Raffaella, Candido, Riccardo, Esposito, Katherine, Giaccari, Andrea, Mannucci, Edoardo, Nicolucci, Antonio, Russo, Giuseppina T
Published in Acta diabetologica (20.05.2024)
Published in Acta diabetologica (20.05.2024)
Get full text
Journal Article